A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Mckesson Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 135,600 shares of MCK stock, worth $71.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
135,600
Previous 124,800 8.65%
Holding current value
$71.3 Million
Previous $67 Million 18.21%
% of portfolio
0.02%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$518.81 - $607.81 $90 Million - $105 Million
-173,458 Reduced 66.53%
87,279 $51 Million
Q1 2024

May 15, 2024

SELL
$473.42 - $539.26 $46.3 Million - $52.7 Million
-97,732 Reduced 27.26%
260,737 $140 Million
Q4 2023

Feb 14, 2024

SELL
$437.42 - $470.64 $22.5 Million - $24.2 Million
-51,454 Reduced 12.55%
358,469 $166 Million
Q3 2023

Nov 14, 2023

SELL
$402.4 - $446.42 $104 Million - $115 Million
-258,096 Reduced 38.64%
409,923 $178 Million
Q2 2023

Aug 14, 2023

BUY
$354.01 - $427.31 $220 Million - $266 Million
622,764 Added 1376.12%
668,019 $285 Million
Q1 2023

May 15, 2023

SELL
$335.35 - $386.06 $22.7 Million - $26.1 Million
-67,649 Reduced 59.92%
45,255 $16.1 Million
Q4 2022

Feb 14, 2023

SELL
$346.68 - $397.58 $117 Million - $134 Million
-336,205 Reduced 74.86%
112,904 $42.4 Million
Q3 2022

Nov 14, 2022

SELL
$321.25 - $373.84 $36.7 Million - $42.8 Million
-114,365 Reduced 20.3%
449,109 $153 Million
Q2 2022

Aug 15, 2022

SELL
$300.57 - $336.42 $32.9 Million - $36.8 Million
-109,512 Reduced 16.27%
563,474 $184 Million
Q1 2022

May 16, 2022

BUY
$244.61 - $310.48 $15.3 Million - $19.4 Million
62,444 Added 10.23%
672,986 $206 Million
Q4 2021

Feb 14, 2022

SELL
$198.21 - $248.9 $16 Million - $20.1 Million
-80,627 Reduced 11.67%
610,542 $152 Million
Q3 2021

Nov 15, 2021

SELL
$188.42 - $208.66 $15.9 Million - $17.6 Million
-84,555 Reduced 10.9%
691,169 $138 Million
Q2 2021

Aug 16, 2021

BUY
$184.89 - $202.68 $105 Million - $115 Million
565,964 Added 269.82%
775,724 $148 Million
Q1 2021

May 17, 2021

SELL
$169.52 - $196.53 $17.4 Million - $20.1 Million
-102,351 Reduced 32.79%
209,760 $40.9 Million
Q4 2020

Feb 16, 2021

BUY
$143.79 - $183.66 $42 Million - $53.7 Million
292,434 Added 1486.17%
312,111 $54.3 Million
Q3 2020

Nov 16, 2020

SELL
$140.89 - $159.9 $120 Million - $136 Million
-850,231 Reduced 97.74%
19,677 $2.93 Million
Q2 2020

Aug 14, 2020

SELL
$125.49 - $164.68 $278 Million - $365 Million
-2,218,688 Reduced 71.83%
869,908 $133 Million
Q1 2020

May 15, 2020

BUY
$115.75 - $170.96 $338 Million - $499 Million
2,916,579 Added 1695.52%
3,088,596 $418 Million
Q4 2019

Feb 14, 2020

BUY
$130.23 - $153.27 $14 Million - $16.5 Million
107,742 Added 167.63%
172,017 $23.8 Million
Q3 2019

Nov 14, 2019

BUY
$134.24 - $148.53 $7.18 Million - $7.95 Million
53,499 Added 496.46%
64,275 $8.78 Million
Q2 2019

Aug 14, 2019

SELL
$112.47 - $134.93 $49.2 Million - $59 Million
-437,149 Reduced 97.59%
10,776 $1.45 Million
Q1 2019

May 15, 2019

BUY
$111.86 - $136.3 $5.48 Million - $6.67 Million
48,967 Added 12.27%
447,925 $0
Q4 2018

Feb 14, 2019

SELL
$108.23 - $136.84 $131 Million - $166 Million
-1,212,983 Reduced 75.25%
398,958 $44.1 Million
Q3 2018

Nov 13, 2018

BUY
$123.14 - $138.52 $190 Million - $214 Million
1,541,786 Added 2197.69%
1,611,941 $0
Q2 2018

Aug 10, 2018

BUY
$133.4 - $158.13 $2.69 Million - $3.19 Million
20,201 Added 40.44%
70,155 $0
Q1 2018

May 11, 2018

BUY
$138.75 - $176.72 $4.79 Million - $6.1 Million
34,526 Added 223.79%
49,954 $7.04 Million
Q4 2017

Feb 09, 2018

BUY
$135.02 - $162.6 $59,138 - $71,218
438 Added 2.92%
15,428 $2.41 Million
Q3 2017

Nov 09, 2017

BUY
$146.0 - $161.87 $2.19 Million - $2.43 Million
14,990
14,990 $2.3 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $75.6B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.